Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SURFACE PROTEIN-A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 146 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Benoist, C; Mathis, D
      Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?

      NATURE IMMUNOLOGY
    2. Mollenkopf, H; Dietrich, G; Kaufmann, SHE
      Intracellular bacteria as targets and carriers for vaccination

      BIOLOGICAL CHEMISTRY
    3. Drabner, B; Guzman, CA
      Elicitation of predictable immune responses by using live bacterial vectors

      BIOMOLECULAR ENGINEERING
    4. Hollingshead, SK; Briles, DE
      Streptococcus pneumoniae: new tools for an old pathogen

      CURRENT OPINION IN MICROBIOLOGY
    5. Jedrzejas, MJ
      Pneumococcal virulence factors: Structure and function

      MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    6. Kouzmitcheva, GA; Petrenko, VA; Smith, GP
      Identifying diagnostic peptides for Lyme disease through epitope discovery

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    7. Whitney, CG; Schaffner, W; Butler, JC
      Rethinking recommendations for use of pneumococcal vaccines in adults

      CLINICAL INFECTIOUS DISEASES
    8. Huppertz, HI
      Lyme disease in children

      CURRENT OPINION IN RHEUMATOLOGY
    9. Van Solingen, RM; Evans, J
      Lyme disease

      CURRENT OPINION IN RHEUMATOLOGY
    10. Kelly, SJ; Taylor, KB; Li, SL; Jedrzejas, MJ
      Kinetic properties of Streptococcus pneumoniae hyaluronate lyase

      GLYCOBIOLOGY
    11. Kolberg, J; Aase, A; Michaelsen, TE; Rodal, G
      Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    12. Ortqvist, A
      Pneumococcal vaccination: current and future issues

      EUROPEAN RESPIRATORY JOURNAL
    13. Steere, AC; Gross, D; Meyer, AL; Huber, BT
      Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis

      JOURNAL OF AUTOIMMUNITY
    14. Klein, JO; Chonmaitree, T; Loosmore, S; Marchant, CD; Ruuskanen, O; Shinefield, HR
      Otitis media: a preventable disease? Proceedings of an International Symposium organized by the Marcel Merieux Foundation, Veyrier-du-Lac, France, February 13 to 16, 2000

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    15. Ohara, N; Yamada, T
      Recombinant BCG vaccines

      VACCINE
    16. Poland, GA; Jacobson, RM
      The prevention of Lyme disease with vaccine

      VACCINE
    17. Mielcarek, N; Alonso, S; Locht, C
      Nasal vaccination using live bacterial vectors

      ADVANCED DRUG DELIVERY REVIEWS
    18. Coffin, SE
      Future vaccines - Recent advances and future prospects

      PRIMARY CARE
    19. Brunner, M; Sigal, LH
      Use of serum immune complexes in a new test that accurately confirms earlyLyme disease and active infection with Borrelia burgdorferi

      JOURNAL OF CLINICAL MICROBIOLOGY
    20. Piesman, J; Schneider, BS; Zeidner, NS
      Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors

      JOURNAL OF CLINICAL MICROBIOLOGY
    21. Depiero, A; Kaminski, DA; Halsey, JF; Briles, D; Burrows, PD; Hostoffer, RW
      Immunologic compensation in a patient with a large IgH constant region deletion

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    22. Smith, G; Wileyto, EP; Hopkins, RB; Cherry, BR; Maher, JP
      Risk factors for Lyme disease in Chester County, Pennsylvania

      PUBLIC HEALTH REPORTS
    23. Steere, AC
      Medical progress: Lyme disease.

      NEW ENGLAND JOURNAL OF MEDICINE
    24. Poland, GA
      Prevention of Lyme disease: A review of the evidence

      MAYO CLINIC PROCEEDINGS
    25. Feder, HM
      Lyme disease vaccine as a strategy for prevention - Reply

      JOURNAL OF PEDIATRICS
    26. Montgomery, RR; Wang, XM; Malawista, SE
      Murine lyme disease: No evidence for active immune down-regulation in resolving or subclinical infection

      JOURNAL OF INFECTIOUS DISEASES
    27. Bockenstedt, LK; Kang, I; Chang, C; Persing, D; Hayday, A; Barthold, SW
      CD4(+) T helper 1 cells facilitate regression of murine Lyme carditis

      INFECTION AND IMMUNITY
    28. Wizemann, TM; Heinrichs, JH; Adamou, JE; Erwin, AL; Kunsch, C; Choi, GH; Barash, SC; Rosen, CA; Masure, HR; Tuomanen, E; Gayle, A; Brewah, YA; Walsh, W; Barren, P; Lathigra, R; Hanson, M; Langermann, S; Johnson, S; Koenig, S
      Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

      INFECTION AND IMMUNITY
    29. Miyaji, EN; Mazzantini, RP; Dias, WO; Nascimento, ALTO; Marcovistz, R; Matos, DS; Raw, I; Winter, N; Gicquel, B; Rappuoli, R; Leite, LCC
      Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM197, a mutant diphtheria toxin

      INFECTION AND IMMUNITY
    30. Talkington, J; Nickell, SP
      Role of Fc gamma receptors in triggering host cell activation and cytokinerelease by Borrelia burgdorferi

      INFECTION AND IMMUNITY
    31. Malawista, SE; Montgomery, RR; Wang, XM; Fu, LL; Giles, SS
      Geographic clustering of an outer surface protein A mutant of Borrelia burgdorferi. Possible implications of multiple variants for Lyme disease persistence

      RHEUMATOLOGY
    32. Shapiro, ED; Gerber, MA
      Lyme disease

      CLINICAL INFECTIOUS DISEASES
    33. Chiao, JW; Villalon, P; Schwartz, I; Wormser, GP
      Modulation of lymphocyte proliferative responses by a canine Lyme disease vaccine of recombinant outer surface protein A (OspA)

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    34. Fischer, W
      Phosphocholine of pneumococcal teichoic acids: role in bacterial physiology and pneumococcal infection

      RESEARCH IN MICROBIOLOGY
    35. Wang, GQ; van Dam, AP; Danker, J
      Two distinct ospA genes among Borrelia valaisiana strains

      RESEARCH IN MICROBIOLOGY
    36. Virolainen, A; Russell, W; Crain, MJ; Rapola, S; Kayhty, H; Briles, DE
      Human antibodies to pneumococcal surface protein A in health and disease

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    37. Malawista, SE
      Resolution of lyme arthritis, acute or prolonged: A new look

      INFLAMMATION
    38. Sood, SK; Ilowite, NT
      Lyme arthritis in children: Is chronic arthritis a common complication?

      JOURNAL OF RHEUMATOLOGY
    39. Obaro, SK
      Confronting the pneumococcus: a target shift or bullet change?

      VACCINE
    40. Himmelrich, H; Lo-Man, R; Winter, N; Guermonprez, P; Sedlik, C; Rojas, M; Monnaie, D; Gheorghiu, M; Lagranderie, M; Hofnung, M; Gicquel, B; Clement, JM; Leclerc, C
      Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: MalE

      VACCINE
    41. Buchan, GS; Young, SL; Lockhart, EA; Wales, J; Faulkner, L; Slobbe, L; Baird, MA
      Targeting early events in T cell activation to construct improved vaccines

      MOLECULAR IMMUNOLOGY
    42. Schoen, RT; Sikand, VK; Caldwell, MC; Van Hoecke, C; Gillet, M; Buscarino, C; Parenti, DL
      Safety and immunogenicity profile of a recombinant outer-surface protein ALyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months

      CLINICAL THERAPEUTICS
    43. Beall, B; Gherardi, G; Facklam, RR; Hollingshead, SK
      Pneumococcal pspA sequence types of prevalent multiresistant pneumococcal strains in the United States and of internationally disseminated clones

      JOURNAL OF CLINICAL MICROBIOLOGY
    44. Ding, W; Huang, XL; Yang, XH; Dunn, JJ; Luft, BJ; Koide, S; Lawson, CL
      Structural identification of a key protective B-cell epitope in lyme disease antigen OspA

      JOURNAL OF MOLECULAR BIOLOGY
    45. Kumar, H; Belperron, A; Barthold, SW; Bockenstedt, LK
      Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi

      JOURNAL OF IMMUNOLOGY
    46. Koga, T; McGhee, JR; Kato, H; Kato, R; Kiyono, H; Fujihashi, K
      Evidence for early aging in the mucosal immune system

      JOURNAL OF IMMUNOLOGY
    47. Katona, LI; Ayalew, S; Coleman, JL; Benach, JL
      A bactericidal monoclonal antibody elicits a change in its antigen, OspB of Borrelia burgdorferi, that can be detected by limited proteolysis

      JOURNAL OF IMMUNOLOGY
    48. Scragg, IG; Kwiatkowski, D; Vidal, V; Reason, A; Paxton, T; Panico, M; Dell, A; Morris, H
      Structural characterization of the inflammatory moiety of a variable majorlipoprotein of Borrelia recurrentis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    49. Nascimento, IP; Dias, WO; Mazzantini, RP; Miyaji, EN; Gamberini, M; Quintilio, W; Gebara, VC; Cardoso, DF; Ho, PL; Raw, I; Winter, N; Gicquel, B; Rappuoli, R; Leite, LCC
      Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice

      INFECTION AND IMMUNITY
    50. Samukawa, T; Yamanaka, N; Hollingshead, S; Klingman, K; Faden, H
      Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract

      INFECTION AND IMMUNITY
    51. Hollingshead, SK; Becker, R; Briles, DE
      Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae

      INFECTION AND IMMUNITY
    52. Maier, B; Molinger, M; Cope, AP; Fugger, L; Schneider-Mergener, J; Sonderstrup, G; Kamradt, T; Kramer, A
      Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    53. Onrust, SV; Goa, KL
      Adjuvanted Lyme disease vaccine - A review of its use in the management ofLyme disease

      DRUGS
    54. Choi, BK; Cho, SH; Bai, GH; Kim, SJ; Hyun, BH; Choe, YK; Bae, YS
      Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guerin in susceptible mice

      DIABETES
    55. Meltzer, MI; Dennis, DT; Orloski, KA
      The cost effectiveness of vaccinating against Lyme disease

      EMERGING INFECTIOUS DISEASES
    56. Hayney, MS; Grunske, MM; Boh, LE
      Lyme disease prevention and vaccine prophylaxis

      ANNALS OF PHARMACOTHERAPY
    57. Yabuki, M; Nakao, M; Fukunaga, M
      Genetic diversity and the absence of regional differences of Borrelia garinii as demonstrated by ospA and ospB gene sequence analysis

      MICROBIOLOGY AND IMMUNOLOGY
    58. White, P; Hermansson, A; Svanborg, C; Briles, D; Prellner, K
      Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media

      ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES
    59. Moore, RJ; Rothel, L; Krywult, J; Radford, AJ; Lund, K; Hodgson, ALM
      Foreign gene expression in Corynebacterium pseudotuberculosis: developmentof a live vaccine vector

      VACCINE
    60. Hayward, CMM; O'Gaora, P; Young, DB; Griffin, GE; Thole, J; Hirst, TR; Castello-Branco, LRR; Lewis, DJM
      Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin

      VACCINE
    61. Supply, P; Sutton, P; Coughlan, SN; Bilo, K; Saman, E; Trees, AJ; Delauw, MFC; Locht, C
      Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii

      VACCINE
    62. Jungblut, PR; Grabher, G; Stoffler, G
      Comprehensive detection of immunorelevant Borrelia garinii antigens by two-dimensional electrophoresis

      ELECTROPHORESIS
    63. Schutzer, SE; Coyle, PK; Reid, P; Holland, B
      Borrelia burgdorferi-specific immune complexes in acute Lyme disease

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    64. Cardenas-Freytag, L; Cheng, L; Mirza, A
      New approaches to mucosal immunization

      MECHANISMS IN THE PATHOGENESIS OF ENTERIC DISEASES 2
    65. Priem, S; Franz, J; Krause, A
      Etiology and pathogenesis of bacterial arthritis - Infectious arthritis, reactive arthritis, Lyme arthritis

      INTERNIST
    66. Barthold, SW
      Specificity of infection-induced immunity among Borrelia burgdorferi sensulate species

      INFECTION AND IMMUNITY
    67. Nowling, JM; Philipp, MT
      Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement

      INFECTION AND IMMUNITY
    68. Sigal, LH
      Lyme arthritis: Lessons learned and to be learned

      ARTHRITIS AND RHEUMATISM
    69. LEBECH AM; HANSEN K; RUTLEDGE BJ; KOLBERT CP; RYS PN; PERSING DH
      DIAGNOSTIC-DETECTION AND DIRECT GENOTYPING OF BORRELIA-BURGDORFERI BYPOLYMERASE-CHAIN-REACTION IN CEREBROSPINAL-FLUID IN LYME NEUROBORRELIOSIS

      Molecular diagnosis
    70. PRIDE MW; BROWN EL; STEPHENS LC; KILLION JJ; NORRIS SJ; KRIPKE ML
      SPECIFIC TH1 CELL-LINES THAT CONFER PROTECTIVE IMMUNITY AGAINST EXPERIMENTAL BORRELIA-BURGDORFERI INFECTION IN MICE

      Journal of leukocyte biology
    71. VASILIU V; HERZER P; ROSSLER D; LEHNERT G; WILSKE B
      HETEROGENEITY OF BORRELIA-BURGDORFERI SENSU-LATO DEMONSTRATED BY AN OSPA-TYPE-SPECIFIC PCR IN SYNOVIAL-FLUID FROM PATIENTS WITH LYME ARTHRITIS

      Medical microbiology and immunology
    72. WORMSER GP; NOWAKOWSKI J; NADELMAN RB; SCHWARTZ I; MCKENNA D; HOLMGREN D; AGUEROROSENFELD M
      EFFICACY OF AN OSPA VACCINE PREPARATION FOR PREVENTION OF LYME-DISEASE IN NEW-YORK-STATE

      Infection
    73. VANHOECKE C; FU D; DEGRAVE D; VOET P; LEBACQ E
      CLINICAL AND IMMUNOLOGICAL ASSESSMENT OF A CANDIDATE LYME-DISEASE VACCINE IN HEALTHY-ADULTS - ANTIBODY PERSISTENCE AND EFFECT OF A BOOSTER DOSE AT MONTH 12

      Vaccine
    74. Kraiczy, P; Peters, S; Seitz, C; Wurzner, R; Oschmann, P; Brade, V
      Growth inhibitory and bactericidal efficacy of sera from Lyme borreliosis patients on B-burgdorferi strains

      WIENER KLINISCHE WOCHENSCHRIFT
    75. GROSS DM; FORSTHUBER T; TARYLEHMANN M; ETLING C; ITO K; NAGY ZA; FIELD JA; STEERE AC; HUBER BT
      IDENTIFICATION OF LFA-1 AS A CANDIDATE AUTOANTIGEN IN TREATMENT-RESISTANT LYME ARTHRITIS

      Science
    76. HUANG XL; YANG XH; LUFT BJ; KOIDE S
      NMR IDENTIFICATION OF EPITOPES OF LYME-DISEASE ANTIGEN OSPA TO MONOCLONAL-ANTIBODIES

      Journal of Molecular Biology
    77. DESILVA AM; FIKRIG E; HODZIC E; KANTOR FS; TELFORD SR; BARTHOLD SW
      IMMUNE EVASION BY TICKBORNE AND HOST-ADAPTED BORRELIA-BURGDORFERI

      The Journal of infectious diseases
    78. GROSS DM; STEERE AC; HUBER BT
      T-HELPER-1 RESPONSE IS DOMINANT AND LOCALIZED TO THE SYNOVIAL-FLUID IN PATIENTS WITH LYME ARTHRITIS

      The Journal of immunology
    79. SOLE M; BANTAR C; INDEST K; GU Y; RAMAMOORTHY R; COUGHLIN R; PHILIPP MT
      BORRELIA-BURGDORFERI ESCAPE MUTANTS THAT SURVIVE IN THE PRESENCE OF ANTISERUM TO THE OSPA VACCINE ARE KILLED WHEN COMPLEMENT IS ALSO PRESENT

      Infection and immunity
    80. JENSEN JR; DUCHATEAU BK; MUNSON EL; CALLISTER SM; SCHELL RF
      INHIBITION OF THE PRODUCTION OF ANTI-OSPA BORRELIACIDAL ANTIBODY WITHT-CELLS FROM HAMSTERS VACCINATED AGAINST BORRELIA-BURGDORFERI

      Infection and immunity
    81. MCDANIEL LS; MCDANIEL DO; HOLLINGSHEAD SK; BRILES DE
      COMPARISON OF THE PSPA SEQUENCE FROM STREPTOCOCCUS-PNEUMONIAE EF5668 TO THE PREVIOUSLY IDENTIFIED PSPA SEQUENCE FROM STRAIN RX1 AND ABILITYOF PSPA FROM EF5668 TO ELICIT PROTECTION AGAINST PNEUMOCOCCI OF DIFFERENT CAPSULAR TYPES

      Infection and immunity
    82. Kremer, L; Dupre, L; Riveau, G; Capron, A; Locht, C
      Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-Transferase from Schistosoma haematobium

      INFECTION AND IMMUNITY
    83. BRILES DE; HOLLINGSHEAD SK; SWIATLO E; BROOKSWALTER A; SZALAI A; VIROLAINEN A; MCDANIEL LS; BENTON KA; WHITE P; PRELLNER K; HERMANSSON A; AERTS PC; VANDIJK H; CRAIN MJ
      PSPA AND PSPC - THEIR POTENTIAL FOR USE AS PNEUMOCOCCAL VACCINES

      Microbial drug resistance
    84. KIM JK; KIM JH; LEE SH; KANG Y; LIM JS; LEE HG; KIM SJ; BAI GH; PARK YK; CHO SH; KANG SW; KIM YS; CHOE IS; CHUNG TW; PARK SN; KIM SH; AHN JS; CHOE YK
      COMPLETE SEQUENCE OF THE UPP GENE ENCODING URACIL PHOSPHORIBOSYLTRANSFERASE FROM MYCOBACTERIUM-BOVIS BCG

      Biochemistry and molecular biology international
    85. HAUPL T; LANDGRAF S; NETUSIL P; BILLER N; CAPIAU C; DESMONS P; HAUSER P; BURMESTER GR
      ACTIVATION OF MONOCYTES BY 3 OSPA VACCINE CANDIDATES - LIPOPROTEIN OSPA IS A POTENT STIMULATOR OF MONOKINES

      FEMS immunology and medical microbiology
    86. LIM EM; LAGRANDERIE M; LEGRAND R; RAUZIER J; GHEORGHIU M; GICQUEL B; WINTER N
      RECOMBINANT MYCOBACTERIUM-BOVIS BCG PRODUCING THE N-TERMINAL HALF OF SIVMAC251 ENV ANTIGEN INDUCES NEUTRALIZING ANTIBODIES AND CYTOTOXIC T-LYMPHOCYTE RESPONSES IN MICE AND GUINEA-PIGS

      AIDS research and human retroviruses
    87. WANG JH; MASUZAWA T; KOMIKADO T; YANAGIHARA Y
      CONSENSUS SEQUENCE ON THE GENES ENCODING THE MAJOR OUTER SURFACE-PROTEINS (OSPA AND OSPB) OF BORRELIA-GARINII ISOLATE

      Microbiology and immunology
    88. BLAAUW AAM; RIJPKEMA SGT; KUIPER H; BIJLSMA JWJ
      LYME-DISEASE - WHO SHOULD BE TESTED AND TREATED, AND HOW

      Netherlands journal of medicine
    89. BRUNET LR; KATAVOLOS P; SPIELMAN A; TELFORD SR
      ANTI-OSPA ANTIBODY REDUCES RESERVOIR COMPETENCE OF MICE FOR BORRELIA-BURGDORFERI, THE AGENT OF LYME-DISEASE

      Medical and veterinary entomology
    90. ERDILE LF; GUY B
      OSPA LIPOPROTEIN OF BORRELIA-BURGDORFERI IS A MUCOSAL IMMUNOGEN AND ADJUVANT

      Vaccine
    91. GERN L; HU CM; VOET P; HAUSER P; LOBET Y
      IMMUNIZATION WITH A POLYVALENT OSPA VACCINE PROTECTS MICE AGAINST IXODES-RICINUS TICK BITES INFECTED BY BORRELIA-BURGDORFERI SS, BORRELIA-GARINII AND BORRELIA-AFZELII

      Vaccine
    92. PROBERT WS; CRAWFORD M; LEFEBVRE RB
      ANTIBODIES TO OSPB PREVENT INFECTION OF C3H MICE CHALLENGED WITH BORRELIA-BURGDORFERI ISOLATES EXPRESSING TRUNCATED OSPB ANTIGENS

      Vaccine
    93. RUTKOWSKI S; BUSCH DH; HUPPERTZ HI
      LYMPHOCYTE-PROLIFERATION ASSAY IN RESPONSE TO BORRELIA-BURGDORFERI INPATIENTS WITH LYME ARTHRITIS - ANALYSIS OF LYMPHOCYTE SUBSETS

      Rheumatology international
    94. ODONNELL MA
      THE GENETIC RECONSTRUCTION OF BCG AS A NEW IMMUNOTHERAPEUTIC TOOL

      Trends in biotechnology
    95. STEERE AC
      DIAGNOSIS AND TREATMENT OF LYME ARTHRITIS

      The Medical clinics of North America
    96. FIKRIG E; BARTHOLD SW; CHEN MC; TAO H; ALISALAAM P; BOCKENSTEDT LK; FLAVELL RA
      LYME BORRELIOSIS IN TRANSGENIC MICE TOLERANT TO OSPA FROM BORRELIA-BURGDORFERI-25015

      The Journal of infectious diseases
    97. LAGRANDERIE M; LOMAN R; DERIAUD E; GICQUEL B; GHEORGHIU M; LECLERC C
      GENETIC-CONTROL OF ANTIBODY-RESPONSES INDUCED BY RECOMBINANT MYCOBACTERIUM-BOVIS BCG EXPRESSING A FOREIGN ANTIGEN

      Infection and immunity
    98. DESILVA AM; FISH D; BURKOT TR; ZHANG Y; FIKRIG E
      OSPA ANTIBODIES INHIBIT THE ACQUISITION OF BORRELIA-BURGDORFERI BY IXODES TICKS

      Infection and immunity
    99. VANDAM AP; OEI A; JASPARS R; FIJEN C; WILSKE B; SPANJAARD L; DANKERT J
      COMPLEMENT-MEDIATED SERUM SENSITIVITY AMONG SPIROCHETES THAT CAUSE LYME-DISEASE

      Infection and immunity
    100. LAHDENNE P; PORCELLA SF; HAGMAN KE; AKINS DR; POPOVA TG; COX DL; KATONA LI; RADOLF JD; NORGARD MV
      MOLECULAR CHARACTERIZATION OF A 6.6-KILODALTON BORRELIA-BURGDORFERI OUTER MEMBRANE-ASSOCIATED LIPOPROTEIN (1P6.6) WHICH APPEARS TO BE DOWN-REGULATED DURING MAMMALIAN INFECTION

      Infection and immunity


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 14:38:45